Literature DB >> 19585378

Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis.

M Y Mok1, S S H Chiu, Y Lo, H K F Mak, W S Wong, P L Khong, C S Lau.   

Abstract

BACKGROUND: Impaired coronary artery reserve has previously been demonstrated in patients with systemic sclerosis (SSc). Both micro- and macrovascular factors are probably contributory to the underlying pathogenesis.
OBJECTIVES: To examine the frequency of coronary atherosclerosis in a series of SSc patients by computed tomography coronary angiography (CTCA), a less invasive method than conventional coronary angiography, the current gold standard in the detection of coronary atherosclerosis, and to explore its clinical associations.
METHODS: Nineteen consecutive SSc patients [six with diffuse (dSSc) and 13 with limited disease (lSSc)] with disease duration of >or= 3 years were recruited. Coronary calcium score and contrast angiography were examined by CT scan. Conventional cardiovascular factors and inflammatory markers were measured and correlated with CT findings.
RESULTS: The mean+/-SD age of these patients was 52.5+/-12.5 years with median disease duration of 12.5 years. Six (31.6%) patients were found to have coronary artery calcification (calcium score 13-2008). Coronary calcium was detected in one dSSc patient but contrast angiography was not performed because of interference from an in situ implantable cardiac device. Some parts of the coronary arteries were not assessable in two patients who had ectopic cardiac rhythm. Five lSSc patients had calcified plaques causing variable coronary luminal stenosis. All patients were asymptomatic. Patients with abnormal CTCA findings were more likely to be older (p < 0.001) and were less likely to have serum anti-Scl70 antibodies (p = 0.003) than those without, after Bonferroni correction.
CONCLUSIONS: Coronary atherosclerosis is not uncommon in asymptomatic SSc patients. CTCA is a convenient and non-invasive method for studying coronary atherosclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19585378     DOI: 10.1080/03009740902992979

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  7 in total

1.  Atherosclerosis in Systemic Sclerosis: a Modern Controversy.

Authors:  Stefania L Magda; Raluca I Mincu; Carmen M Mihai; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Buchar)       Date:  2015-09

2.  Risk factors for coronary heart disease in connective tissue diseases.

Authors:  Awal Al Husain; Ian N Bruce
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

Review 3.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

Review 4.  The burden and measurement of cardiovascular disease in SSc.

Authors:  Mo Yin Mok; Chak Sing Lau
Journal:  Nat Rev Rheumatol       Date:  2010-06-01       Impact factor: 20.543

Review 5.  "How many times must a man look up before he can really see the sky?" Rheumatic cardiovascular disease in the era of multimodality imaging.

Authors:  Sophie I Mavrogeni; George Markousis-Mavrogenis; David Heutemann; Kees van Wijk; Hans J Reiber; Genovefa Kolovou
Journal:  World J Methodol       Date:  2015-09-26

6.  Atherosclerotic plaques occur in absence of intima-media thickening in both systemic sclerosis and systemic lupus erythematosus: a duplexsonography study of carotid and femoral arteries and follow-up for cardiovascular events.

Authors:  Marc Frerix; Johannes Stegbauer; Alexander Kreuter; Stefan Markus Weiner
Journal:  Arthritis Res Ther       Date:  2014-02-19       Impact factor: 5.156

7.  Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study.

Authors:  Annica Nordin; Kerstin Jensen-Urstad; Lena Björnådal; Susanne Pettersson; Anders Larsson; Elisabet Svenungsson
Journal:  Arthritis Res Ther       Date:  2013-08-14       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.